Western Economic Diversification Canada Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2006
NCT00359125
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Western Economic Diversification Canada

Active Ingredients

Drugs in Phase 2 Trials (2)

mifepristone (mifeprex) (1 trial)

nimotuzumab (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Bipolar Disorder (Phase 2)

Depression (Phase 2)

Depressive Disorder (Phase 2)

Lung Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2